Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
TB-500 is a synthetic fragment of Thymosin Beta-4, a protein your body produces naturally in response to injury
It has also been shown to upregulate the expression of the early growth response gene-1 (Egr-1), a transcription factor that orchestrates the expression of multiple growth factors involved in wo Research Evidence Promotes VEGFR2-mediated angiogenesis in preclinical wound models (McGuire et al., 2025)Stimulates fibroblast migration and tendon outgrowth in ex vivo explant studies (Sikiric et al., 2021)Upregulates Egr-1 transcription factor, driving growth factor expression cascadeDemonstrates stability under physiological conditions due to high proline contentModulates nitric oxide signaling pathways in gastrointestinal and vascular tissue models Bottom line: BPC-157 is one of the most extensively studied synthetic peptides in preclinical regenerative research
The consistency of preclinical results and the plausible mechanisms give me reasonable confidence that the peptide does something meaningful biologically
Radoslav Bozic at the University of Zagreb, Croatia
TB 500 increases flexibility, improves blood flow, and speeds recovery by stimulating tissue regeneration
